|

The EPA and FDA would have expectant mothers reduce
or eliminate their intake of seafood due to the
possibility that the small amount of methyl mercury
contained in some fish might adversely affect their unborn
offspring. However, studies have shown that the
benefits of eating seafood far outweigh the risks, for
all age groups and both sexes. Can the same be said of mercury
amalgam restorations (see Development)?
If not, why aren't the EPA and FDA clamoring for the
elimination of mercury amalgam restorations at least in
pregnant women, women of child bearing age, and
children? Despite their assertions, a panel of
experts convened by the World Health Organization in
1991, determined that mercury amalgam fillings were the
primary source of mercury exposure in the
non-occupationally exposed population and NOT SEAFOOD!!
(see Mercury Exposure)
In other words the FDA and EPA would have us believe
that consuming fish that MIGHT contain a small
amount of mercury should be avoided despite its many
health benefits but having a dentist put in a mercury
amalgam filling that DEFINITELY contains mercury,
some as much as 500 mg, 5 cm from a child's brain is somehow OK.

TABLE OF CONTENTS
 |
Fish
Consumption and Risk of Stroke in Men
 | JAMA,
Vol. 288 No. 24, December 25, 2002 |
|
 | Association
between prenatal exposure to
methylmercury and developmental outcomes in
Seychellois children: effect modification by social
and environmental factors. |
 | Mercury in Seafood
 | From the Mercury Policy Project |
|
 | Low
consumption of seafood in early pregnancy as a risk
factor for preterm
delivery: prospective cohort study |
 | Commercial
Fish: Eat Up, Despite Low Levels Of Mercury |
 | Blood Levels of
Long-Chain n–3 Fatty Acids and the Risk of Sudden
Death |
 | N-3 and N-6
fatty acids in breast adipose tissue and relative
risk of breast cancer
in a case-control study in Tours, France. |
 | Age-Related
Cognitive Decline and Fish
Consumption - Omega-3 Fatty Acids Improve
Cognitive Function |
 |
Intake
of Fish and Omega-3 Fatty Acids and Risk of Stroke
in Women |
 |
Fatty
fish consumption and risk of prostate
cancer |

Association
between prenatal exposure to
methylmercury and developmental outcomes in Seychellois
children: effect modification by social and
environmental factors.
Neurotoxicology 1999
Oct;20(5):833-41
http://www.ncbi.nlm.nih.gov:80/entrez/queryPubMed&list_uids=10591519&dopt=Abstract
Davidson PW, Myer GJ, Shamlaye C, Cox
C, Gao P, Axtell C, Morris D, Sloane-Reeves J,
Cernichiari E, Choi A, Palumbo D, Clarkson TW.
Department of Pediatrics, University of Rochester
School of Medicine and Dentistry, New York 14642, USA. phil_davidson@urmc.rochester.edu
The Seychelles Child Development Study (SCDS) is
testing the hypothesis that prenatal exposure to low
doses of MeHg from maternal consumption of fish is
associated with the child's developmental outcomes. No
deleterious relationships between exposure to MeHg and
cognitive functions have been identified in the primary
analysis of the main cohort through 66 months of age.
We performed secondary analyses to determine if effect
modification (EM) from social and environmental factors
was affecting associations between MeHg and outcomes.
METHODS: MeHg exposure was determined
by analysis of maternal hair growing during pregnancy.
Children in our Main Study cohort were evaluated at 6.5
months (N = 740) for visual recognition memory and
visual attention using the Fagan Infantest, at 19 months
(N = 738) and 29 months (N = 736) with the Bayley Scales
of Infant Development (BSID). Interactions between MeHg
and Caregiver Intelligence, Family Income and Home
Environment were examined by multiple regression
analysis. RESULTS: The median prenatal MeHg exposure was
5.9 ppm (Range 0.5-26.7 ppm). No EM occurred for
preferential looking or visual attention at 6.5 months,
for the BSID Psychomotor Scale at either 19 or 29
months, or for activity level at 29 months as measured
by the BSID Infant Behavior Record. Interactions between
MeHg level and both caregiver intelligence and family
income were statistically significant for the BSID
Mental Scale at 19 months but not at 29 months. These
showed enhancement of MDI scores with increasing
maternal MeHg in higher caregiver IQ groups at several
levels of family income.
CONCLUSIONS: In Seychellois children,
consistent major EM by social or environmental factors
were not identified. The small EM by caregiver
intelligence and social factors at 19 months is
consistent with the enhanced performance
we reported when this cohort was examined at 66 months.

Eat Fish for Healthy
Pregnancy
http://health.discovery.com/news/reu/20020218/eatfish.html
http://bmj.com/cgi/content/full/324/7335/447
02/22/202 — LONDON (Reuters) - Eating fish
can improve a woman's chances of having a full-term
pregnancy and a healthy, bouncy baby, Danish researchers
said on Friday.
They suspect that fish, which is rich in omega-3
fatty acids, can increase the child's birth weight by
prolonging the pregnancy and preventing premature
births.
He and his colleagues compared the diets of 8,000
Danish women during pregnancy to determine if seafood
had an impact on early births.
"Low consumption of fish was a strong risk
factor for pre-term delivery and low birth weight,"
said Sjurour Frooi Olsen, a researcher at the Statens
Serum Institute in Copenhagen.
In the study reported in the British Medical
Journal, the women were asked how often they ate
fish during their pregnancy and whether it was in a hot
meal, salad or if they took a fish oil supplement.
The researchers found that women who ate the most
fish had fewer premature births and smaller babies than
those who did not.
Pre-term deliveries fell from 7.1 percent in women
who never ate fish to 1.9 percent in expectant mothers
who ate fish at least once a week.
Olsen said his findings agreed with previous studies
which found a link between fish consumption and
full-term pregnancies.
Oily fish such as salmon, herring and mackerel are
rich in omega-3 fatty acids, which have also been found
to be effective in fighting depression and in inhibiting
the growth of prostate cancer cells.

Mom's
fish intake linked to preterm delivery risk
By Amy Norton
From Reuters Health
NEW YORK, Feb 22 (Reuters Health) - A
new study links low consumption of fish early in
pregnancy to higher odds of preterm delivery and low
birth weight--suggesting, researchers say, that the
omega-3 fatty acids in fish and fish oil supplements
might help prevent these complications.
Together with past research suggesting fish oil may
lower the risk of premature delivery, these findings lay
the groundwork for clinical trials on the effects of
omega-3 fatty acids during pregnancy, researchers
conclude in the February 23rd issue of the British
Medical Journal.
Their study of more than 8,700 pregnant women in
Denmark found that those who said they currently ate no
fish were around three times more likely than those who
ate the most to have a preterm delivery.
But an expert not involved in the study told Reuters
Health that while the findings are
"interesting," pregnant women should not take
them to mean that eating more fish is necessarily a good
thing. Moreover, there are health concerns surrounding
high fish consumption--particularly for pregnant
women--because some fish can contain significant amounts
of metals like lead and mercury, said Dr. David Nagey of
Johns Hopkins University in Baltimore, Maryland.
Overall, women who ate some fish were less likely
than those who did not to deliver prematurely, and their
babies tended to weigh more. For instance, the rate of
premature birth among women who ate no fish was about
7%, compared with roughly 2% for women who had fish at
least once a week.
But there was no clear "dose-response"
relationship between fish intake and the risks of
preterm delivery and low birth weight, Nagey pointed
out. This means that the risks did not continue to
decline as women's fish intake rose. According to Nagey,
this suggests other factors could explain the link--or,
he noted, there could be a negative effect from eating a
lot of fish that counters the benefits of moderate
consumption.
Indeed, some fish are considered risky during
pregnancy. In the US, the Food and Drug Administration
advises pregnant women to avoid eating shark, swordfish,
king mackerel and tilefish because they may contain high
levels of mercury, which can potentially harm the
developing fetal nervous system. Mercury occurs
naturally in the environment and as a byproduct of
industrial pollution; it can accumulate in certain
long-lived fish that consume other fish.
In the current study, Dr. Sjurour Frooi Olsen, of
Statens Serum Institut in Copenhagen, and Dr. Niels
Jorgen Secher questioned women on their fish intake, as
well as smoking
and alcohol consumption. They also accounted for factors
such as age, weight before pregnancy and education. None
of the women were taking fish oil supplements.
According to the researchers, their results suggest
that for women who eat little or no fish, small amounts
of omega-3 fatty acids--through either fish or fish oil
supplements--might help reduce the odds of preterm
delivery or low birth weight.
But Nagey said that drawing such conclusions from
these findings is "irresponsible."
Olsen, however, told Reuters Health that their study
suggests even eating small amounts of fish could be
beneficial, so the risks of pollutant contamination
would be low. If women have concerns, the researcher
noted, they can contact local health authorities for
information on pollutant levels in various fish species.
SOURCE: British Medical Journal
2002;324:447-450.

Fish
oil may reduce risk of irregular
heartbeat
By Charnicia E. Huggins
Source: Circulation
2002;105
http://www.reutershealth.com/archive/2002/04/08/eline/links/20020408elin010.html
NEW YORK, Apr 08 (Reuters Health) -
Previous studies have suggested that fish oil
supplements may reduce the risk of an additional heart
attack or stroke
in patients who have recently experienced a heart
attack. Now new study findings reveal that the
supplement may also reduce the risk of sudden death.
The findings show that this reduced risk was evident
after as few as 3 months, which seems to support the
hypothesis that adding n-3 polyunsaturated fatty acids (PUFAs)--commonly
found in fish and fish oil--to a healthy diet may lower
the risk of fatal arrhythmia, an irregular heartbeat
that in severe cases can lead to cardiac arrest, the
authors report.
"Reduction of sudden death appeared early after
start of treatment," lead study author Dr. Roberto
Marchioli, of Consorzio Mario Negri Sud in Italy, told
Reuters Health. This "seems to support the idea
that (the benefits of PUFAs) could be due to an anti-arryhythmia
effect," he added.
The study included 11,323 patients who had suffered a
heart attack within the previous 3 months. All of the
patients received the same preventive care and ate
Mediterranean-style diets rich in fruits, vegetables,
olive oil and fish. But some patients also consumed 1
gram of the fish oil supplements per day.
During the 3.5-year follow-up period, 1,031
individuals died, Marchioli and his colleagues report in
the April issue of the Circulation: Journal of the
American Heart Association.
Patients who took the fish oil supplements appeared
to be at a 41% lower risk of death from any cause after
only 3 months of treatment, study findings indicate.
After 4 months of treatment, these patients also
appeared to be at a significantly reduced risk of sudden
cardiac death. And by the end of the study period,
patients treated with fish oil supplements were 45% less
likely to die suddenly from a heart-related cause,
Marchioli and his colleagues report.
In light of the findings, Marchioli said that the
benefit of fish oil supplements "seems to be
additive to the benefit that can be obtained by standard
preventive treatment."
"One capsule of a fish oil concentrate daily for
3.5 years resulted in a very significant reduction in
sudden cardiac death. Thus, a simple and safe change in
diet can potentially produce a large public health
benefit," editorialist Dr. Alexander Leaf of
Harvard Medical School in Boston, Massachusetts, told
Reuters Health.
"Individuals who have known coronary heart
disease or a family history of coronary heart disease
among immediate relatives would be prudent to heed the
recent advice of the American Heart Association to eat
two or more meals of oily fish per week or take a daily
supplement of fish oil capsules," Leaf added.
SOURCE: Circulation 2002;105.

Blood
Levels of Long-Chain n–3 Fatty Acids and the Risk of Sudden
Death
Christine M. Albert, M.D., M.P.H.,
Hannia Campos, Ph.D., Meir J. Stampfer, M.D., Dr.P.H.,
Paul M. Ridker, M.D., M.P.H., JoAnn E. Manson, M.D.,
Dr.P.H., Walter C. Willett, M.D., Dr.P.H., and Jing Ma,
M.D., Ph.D.
New England Journal of Medicine Volume
346:1113-1118 April 11, 2002 Number 15
http://content.nejm.org/cgi/content/short/346/15/1113
ABSTRACT
Background Experimental data suggest that
long-chain n–3 polyunsaturated fatty acids
found in fish have antiarrhythmic properties,
and a randomized trial suggested that dietary
supplements of n–3 fatty acids may reduce
the risk of sudden death among survivors of
myocardial infarction. Whether long-chain n–3
fatty acids are also associated with the risk of sudden
death in those without a history of cardiovascular
disease is unknown.
Methods We conducted a prospective, nested
case–control analysis among apparently
healthy men who were followed for up to 17
years in the Physicians' Health Study. The fatty-acid
composition of previously collected blood was
analyzed by gas–liquid chromatography for
94 men in whom sudden death occurred as the first
manifestation of cardiovascular disease and for 184
controls matched with them for age and
smoking status.
Results Base-line blood levels of long-chain
n–3 fatty acids were inversely related to
the risk of sudden death both before
adjustment for potential confounders (P for trend =
0.004) and after such adjustment (P for trend
= 0.007). As compared with men whose blood
levels of long-chain n–3 fatty acids were
in the lowest quartile, the relative risk of sudden
death was significantly lower among men with
levels in the third quartile (adjusted
relative risk, 0.28; 95 percent confidence interval,
0.09 to 0.87) and the fourth quartile (adjusted
relative risk, 0.19; 95 percent confidence
interval, 0.05 to 0.71).
Conclusions The n–3 fatty acids found in
fish are strongly associated with a reduced
risk of sudden death among men without evidence
of prior cardiovascular disease.
Source
Information
From the Division of Preventive
Medicine (C.M.A., P.M.R., J.E.M.), the Channing
Laboratory (M.J.S., J.E.M., W.C.W., J.M.), and the
Division of Cardiovascular Medicine (P.M.R.), Department
of Medicine, Brigham and Women's Hospital; the
Cardiovascular Division, Department of Medicine,
Massachusetts General Hospital (C.M.A.); and the
Departments of Nutrition (H.C., M.J.S., W.C.W.) and
Epidemiology (M.J.S., J.E.M., W.C.W.), Harvard School of
Public Health — all in Boston.
Address reprint requests to Dr.
Albert at the Division of Preventive Medicine, Brigham

Fish
and Omega-3 Fatty Acid Intake and Risk of Coronary
Heart Disease in Women
Frank B. Hu, MD; Leslie Bronner, MD; Walter C.
Willett, MD; Meir J. Stampfer, MD; Kathryn M. Rexrode,
MD; Christine M. Albert, MD; David Hunter, MD; JoAnn E.
Manson, MD
JAMA, Vol. 287 No. 14, April 10,
2002
http://jama.ama-assn.org/issues/v287n14/abs/joc11695.html
Context Higher consumption of fish
and omega-3 fatty acids has been associated with a lower
risk of coronary heart disease (CHD) in men, but limited
data are available regarding women.
Objective To examine the
association between fish and long-chain omega-3 fatty
acid consumption and risk of CHD in women.
Design, Setting, and Participants Dietary
consumption and follow-up data from 84 688 female
nurses enrolled in the Nurses' Health Study, aged 34 to
59 years and free from cardiovascular disease and cancer
at baseline in 1980, were compared from validated
questionnaires completed in 1980, 1984, 1986, 1990, and
1994.
Main Outcome Measures Incident
nonfatal myocardial infarction and CHD deaths.
Results During 16 years of
follow-up, there were 1513 incident cases of CHD (484
CHD deaths and 1029 nonfatal myocardial infarctions).
Compared with women who rarely ate fish (<1 per
month), those with a higher intake of fish had a lower
risk of CHD. After adjustment for age, smoking, and
other cardiovascular risk factors, the multivariable
relative risks (RRs) of CHD were 0.79 (95% confidence
interval [CI], 0.64-0.97) for fish consumption 1 to 3
times per month, 0.71 (95% CI, 0.58-0.87) for once per
week, 0.69 (95% CI, 0.55-0.88) for 2 to 4 times per
week, and 0.66 (95% CI, 0.50-0.89) for 5 or more times
per week (P for trend = .001). Similarly, women
with a higher intake of omega-3 fatty acids had a lower
risk of CHD, with multivariable RRs of 1.0, 0.93, 0.78,
0.68, and 0.67 (P<.001 for trend) across
quintiles of intake. For fish intake and omega-3 fatty
acids, the inverse association appeared to be stronger
for CHD deaths (multivariate RR for fish consumption 5
times per week, 0.55 [95% CI, 0.33-0.90] for CHD deaths
vs 0.73 [0.51-1.04]) than for nonfatal myocardial
infarction.
Conclusion Among women, higher
consumption of fish and omega-3 fatty acids is
associated with a lower risk of CHD, particularly CHD
deaths.
JAMA. 2002;287:1815-1821

N-3 and N-6 fatty
acids in breast adipose tissue and relative risk of breast
cancer in a case-control study in Tours, France.
Maillard V, Bougnoux P, Ferrari P, Jourdan ML,
Pinault M, Lavillonniere F, Body G, Le Floch O, Chajes
V.
Laboratoire de Biologie des Tumeurs, Clinique
d'Oncologie-Radiotherapie, Service de
Gynecologie-Obstetrique, E.A. 2103, Unite de Recherche
Associee Universite-INRA, CHU, Tours, France.
Int J Cancer 2002 Mar 1;98(1):78-83
http://www.ncbi.nlm.nih.gov/entrez/PubMed&list_uids=11857389&dopt=Abstract
Experimental studies have indicated that n-3 fatty
acids, including alpha-linolenic acid (18:3 n-3) and
long-chain n-3 polyunsaturated fatty acids inhibit
mammary tumor growth and metastasis. Earlier
epidemiological studies have given inconclusive results
about a potential protective effect of dietary n-3
polyunsaturated fatty acids on breast cancer risk,
possibly because of methodological issues inherent to
nutritional epidemiology. To evaluate the hypothesis
that n-3 fatty acids protect against breast cancer, we
examined the fatty acid composition in adipose tissue
from 241 patients with invasive, nonmetastatic breast
carcinoma and from 88 patients with benign breast
disease, in a case-control study in Tours, central
France. Fatty acid composition in breast adipose tissue
was used as a qualitative biomarker of past dietary
intake of fatty acids. Biopsies of adipose tissue were
obtained at the time of surgery. Individual fatty acids
were measured as a percentage of total fatty acids,
using capillary gas chromatography. Unconditional
logistic regression modeling was used to obtain odds
ratio estimates while adjusting for age, height,
menopausal status and body mass index. We found inverse
associations between breast cancer-risk and n-3 fatty
acid levels in breast adipose tissue. Women in the
highest tertile of alpha-linolenic acid (18:3 n-3) had
an odds ratio of 0.39 (95% confidence intervals [CI] =
0.19-0.78) compared to women in the lowest tertile
(trend p = 0.01). In a similar way, women in the highest
tertile of docosahexaenoic acid (22:6 n-3) had an odds
ratio of 0.31 (95% CI = 0.13-0.75) compared to women in
the lowest tertile (trend p = 0.016). Women in the
highest tertile of the long-chain n-3/total n-6 ratio
had an odds ratio of 0.33 (95% confidence interval =
0.17-0.66) compared to women in the lowest tertile
(trend p = 0.0002). In conclusion, our data based on
fatty acids levels in breast adipose tissue suggest a
protective effect of n-3 fatty acids on breast cancer
risk and support the hypothesis that the balance between
n-3 and n-6 fatty acids plays a role in breast cancer.
Copyright 2001 Wiley-Liss, Inc.

BMJ 2002;324:447 ( 23 February )
Papers
Low consumption of seafood in
early pregnancy as a risk factor for preterm
delivery: prospective cohort study
Sjúr ur
Fró i Olsen,
associate professor a, Niels
Jørgen Secher, professor b.
a Maternal Nutrition Group, Danish
Epidemiology Science Centre, Statens Serum Institut,
Artillerivej 5, DK-2300 Copenhagen S, Denmark, b Perinatal
Epidemiology Research Unit, Department of Obstetrics and
Gynaecology, Skejby University Hospital, DK-8200 Aarhus
N, Denmark
Correspondence to: S F Olsen sfo@ssi.dk
http://bmj.com/cgi/content/full/324/7335/447
Abstract
Objective: To determine the relation between
intake of seafood in pregnancy and risk of
preterm delivery and low birth weight.
Design: Prospective cohort study.
Setting: Aarhus, Denmark.
Participants: 8729 pregnant women.
Main outcome measures: Preterm delivery and
low birth weight.
Results: The occurrence of preterm delivery
differed significantly across four groups of
seafood intake, falling progressively from
7.1% in the group never consuming fish to 1.9% in the
group consuming fish as a hot meal and an
open sandwich with fish at least once a week.
Adjusted odds for preterm delivery were increased by
a factor of 3.6 (95% confidence interval 1.2 to
11.2) in the zero consumption group compared
with the highest consumption group. Analyses
based on quantified intakes indicated that the working
range of the dose-response relation is mainly from
zero intake up to a daily intake of 15 g
fish or 0.15 g n-3 fatty acids. Estimates of
risk for low birth weight were similar to those for
preterm delivery.
Conclusions: Low consumption of fish was a
strong risk factor for preterm delivery and
low birth weight. In women with zero or low
intake of fish, small amounts of n-3 fatty acids provided
as fish or fish oil may
confer protection against preterm delivery and
low birth weight.
|
What is already known on this
topic
Long chain n-3 fatty acids in amounts above 2 g
a day may delay spontaneous delivery and prevent
recurrence of preterm delivery
Large studies have not been carried out to
determine to what extent low consumption of n-3
fatty acids is a risk factor for preterm
delivery
The dose-response relation has not been
described
What this study adds
Low consumption of fish seems to be a strong
risk factor for preterm delivery and low birth
weight in Danish women
This relation is strongest below an estimated
daily intake of 0.15 g long chain n-3 fatty
acids or 15 g fish
|
Introduction
It is important to identify modifiable causes of
preterm delivery and fetal growth retardation, which are
strong predictors of infants' later health
and survival. Observations of high birth weights1
and long gestations2 in the
fish eating community of the Faroe Islands
suggested that intake of seafood rich in long
chain n-3 fatty acids can increase birth weight by
prolonging gestation2
or by increasing the fetal growth rate.3-6
Fish oil has been shown in randomised trials 7
8 and animal experiments 9
10 to have the potential
to delay spontaneous delivery and prevent
preterm delivery, but the minimum amount of
n-3 fatty acids needed to obtain this effect remains to
be determined. No detectable effects on fetal
growth rate were seen in these trials, 7
8 but fish oil was provided
only in the second half of pregnancy, and
several observational studies have found
direct associations between measures of seafood intake
in pregnancy and fetal growth rate. 5
11-14
We investigated these issues in a cohort of women in
whom seafood intake in early pregnancy was assessed
prospectively by a questionnaire method.15
We tested whether a low intake of seafood in
early pregnancy is a risk factor for preterm delivery
and low birth weight and whether it is associated
with a lower fetal growth rate. We related
the findings to quantified intakes of fish
and long chain n-3 fatty acids.
Discussion
Low consumption of seafood was a strong risk factor
for preterm delivery and low birth weight. The
associations were strongest below a daily
intake of 0.15 g long chain n-3 fatty acids or 15 g
fish.
Strengths and weaknesses
Strengths of the study included that exposure data
were collected in a concurrent fashion and long before
occurrence of outcome among more than 8000 women,
that exposure categories and other analytical
conditions were decided a priori, and that analyses
took account of nine potential confounding factors.
The main weakness of the study, as with any
observational study, was the possibility of confounding
that was not adjusted for. Adjustment had
little impact on measures of association, but
confounding by unmeasured factors cannot be ruled out.
Another weakness was that the assumed values for
portion sizes, distributions of fish species in meals,
and food contents of nutrients are only
approximations to the true values. Imprecise estimates
of quantified intake of n-3 fatty acids are thus
inevitable. Although this imprecision is
unlikely to explain the steep decline in risk
at the low end of the exposure distribution, it may
contribute to the observed
"bending" of the relation if imprecision
increases with increasing exposure, a
possibility that cannot be ruled out.
Alternative strategy
The alternative strategy was free of these assumptions
as it simply used the questions on food frequency to
define four groups with large differences in exposure;
the questions had been shown to be strong and
mutually independent predictors of n-3 fatty
acids measured in erythrocytes in the same
population.15 It is
therefore reassuring that this strategy corroborated
the finding of a steep decline in risk across the lowest
exposure groups, although with only four groups it was
not possible to draw conclusions about levelling
off at high exposures.
Comparisons with other studies
Overall, the findings agree with the randomised trials
showing that consumption of fish oil in pregnancy can
increase birth weight by prolonging gestation
and reduce the risk of recurrence of preterm
delivery. 7 8
The finding that the dose-response relations
were strong at low exposures corroborates two earlier
studies. A reduction in early delivery was seen in
women who had received only 0.1 g n-3
fatty acids (along with other substances) a
day from week 20 of gestation.20-23
An association was seen between duration of
pregnancy and a biomarker for intake of marine n-3 fatty
acids (fatty acids measured in erythrocyte lipids) in
Danish women, whereas no such association
could be detected in Faroese women with a
substantially higher intake, suggesting a stronger association
at low exposures.24
A case-control study in the same population could not
detect any association between seafood intake in
pregnancy and risks of preterm birth25;
unlike the present study, however, this study
assessed dietary intake retrospectively after delivery,
which may have distorted the results and led to
the null finding.
Several observational studies have found associations
between measures of maternal seafood intake and fetal
growth rate. 5 11-14
In the randomised trials, where fish oil was provided
after week 16-20 of gestation, no
effects were seen on fetal growth rate. 7
8 The observational data
could therefore possibly be explained either by
effects of n-3 fatty acids exerted before week 16-20 or
by effects of other substances in seafood.
Our study could substantiate neither of these
two possibilities, as the associations between seafood
consumption in early pregnancy and fetal growth rate
tended to disappear after adjustment for
potential confounders.
Randomised controlled trials to examine the
dose-response relations between long chain n-3 fatty
acids and timing of delivery and preterm risk
are warranted.

Commercial
Fish: Eat Up, Despite Low Levels Of Mercury
Source University of Rochester (http://www.rochester.edu/)
Date posted 8/27/1998
http://www.sciencedaily.com/releases/1998/08/980827074214.htm
Even though the world's fish
contain slight amounts of mercury, eating lots of fish
carries no detectable health risk from low levels of the
substance, even for very young children and pregnant
women, concludes the most comprehensive study of the
subject yet.
The findings come from a nine-year University of
Rochester study conducted in the Republic of the
Seychelles, an island nation in the Indian Ocean where
most people eat nearly a dozen fish meals each week and
whose mercury levels are about 10 times higher than most
U.S. citizens. Indeed, no harmful effects were seen in
children at levels up to 20 times the average U.S.
level. The work is published in the August 26 issue of
the Journal of the American Medical Association.
"We look at the Seychelles people as a sentinel
population," says pediatric neurologist Gary Myers,
who examined the children. "If somebody who eats
fish twice a day does not show effects from mercury
exposure, it's unlikely that somebody who eats fish
twice a week will be affected. And the fish they eat in
the Seychelles contains the same amount of mercury as
fish sold at supermarkets and eaten in the United
States."
Adds first author Philip Davidson, an expert on
developmental disabilities who designed a battery of the
most sophisticated tests available to examine the
children: "What we found in the Seychelles is
applicable to every woman, every man, and every child
around the world who eats ocean fish."
In the United States the green light applies only to
fish bought and sold commercially, at grocery stores,
supermarkets, fish shops, and in restaurants. Those fish
are already regulated based on their mercury levels, and
current regulations are sufficient to safeguard frequent
fish eaters against mercury exposure, say the
investigators. Consumers still should follow advisories
about eating fish caught in lakes and rivers, since
there are hundreds of polluted waterways whose fish are
dangerous to eat in abundance, often because of other
pollutants such as PCBs.
The Seychelles study began in 1989, when Rochester
researchers, with decades of expertise studying mercury
exposure, chose the nation of about 65,000 people as an
ideal site to study the effects of mercury exposure (see
sidebar). Myers enrolled 779 newborn children, about
half the births on the islands that year. From the
children's mothers, Myers and the team took samples of
hair, which lock in a record of mercury exposure of the
child during gestation.
A neurologist, a childhood development expert, and
nurses then studied the children at 6, 19, 29 and 66
months of age, visiting their homes, talking to their
parents, and performing nearly three dozen sensitive
developmental and neurological tests designed to detect
subtle effects of mercury exposure. The analysis
included noting when the children learned to walk and
talk, measurements of reflexes, word recognition, and
social behavior, and the best neuropsychological tests
yet developed to evaluate children at these ages. At
each interval, the results of the longitudinal study
have been consistent: no ill effects from a high-fish
diet. The JAMA paper details the 66-month evaluation,
which included 711 of the original children.
Mercury is a deadly neurotoxin that at high levels
kills nerve cells, causing blurry vision, lack of
coordination, slurred speech, and even death. Children
exposed to high levels of the compound pre-natally can
suffer slowed development, blindness, cerebral palsy,
and other birth defects.
While high amounts of mercury are obviously toxic,
scientists for years have debated the health effects of
lower levels. Late last year, the federal Environmental
Protection Agency (EPA) proposed slashing the amount of
mercury that is acceptable for people to ingest from 30
micrograms per day, the level recommended both by the
World Health Organization and the federal Agency for
Toxic Substances and Disease Registry, to just six. If
the Food and Drug Administration (FDA) follows this
guideline, it will need to slash the current level of
mercury allowable in ocean fish that are sold in the
United States below the current level of 1 part per
million (ppm).
That action would take off the market a significant
proportion of the fish now available, especially large
predatory fish like swordfish, shark, and red snapper,
and could even affect tuna. The team fears that it might
also convince consumers who associate mercury with
health dangers to limit their intake of fish, a
remarkably healthy form of nutrition. Under the proposed
rules, scientists estimate that the average person would
be able to eat only a few ounces of fish per week before
bumping up against the new limit.
"Eating lots of ocean fish isn't much of a
hazard compared to missing out on the benefits from not
eating fish," says Thomas Clarkson, professor of
environmental medicine and an internationally recognized
authority on mercury. Clarkson is principal investigator
of the study, which is being funded by the National
Institutes of Health, the Food and Drug Administration,
and the Republic of the Seychelles.
"A slew of scientific reports have shown that
eating fish helps protect against cardiovascular disease
and enhances brain development before and after birth.
Fish is a rich source of low- fat protein and is full of
fatty acids known to lower cholesterol. Overstating the
almost negligible risk of mercury could adversely affect
millions of people who face the risk of heart
disease," says Clarkson. He adds that FDA's current
guideline already helps people avoid excessive mercury
exposure, which would be a danger primarily for someone
eating frequent meals of fish like swordfish and shark.
Fish are the primary source of exposure to mercury
around the world. Scientists estimate that about half
the mercury in the Earth and its atmosphere originates
from natural sources such as volcanoes that belch
massive quantities of the substance. Man- made sources
include coal-fired power plants, smoke from burning
cigarettes, and incinerators that burn items like
fluorescent bulbs, batteries, and mercury thermometers.
Mercury vapor enters the atmosphere and falls in
rainwater to the Earth. Then, in a poorly understood
process in the oceans and other bodies of water,
microbes play a key role, transforming the mercury into
a substance known as methyl mercury, which works its way
up the food chain and accumulates primarily in large
predatory fish, though methyl mercury is found in
virtually all fish around the globe.
While the study focused on healthy fish from ocean
waters, its implications spill over into the freshwater
arena too. Mercury is one of many pollutants that limit
consumption of fish from lakes and rivers across the
nation, and individual states rely on federal guidelines
when developing recommendations on how many fish can be
eaten per week or month. If federal agencies lower the
level of mercury they say is acceptable in the diet,
that would likely force states to recommend that
residents eat fewer fish from local waters.
The Rochester team is continuing the study and is
currently analyzing the same group of children at eight
years of age. The scientists are also working with
nutrition experts from the University of Ulster in
Northern Ireland to explain an unexpected finding: As
mercury levels in the children went up, so did their
performance on tests.
That link could be due to several factors, scientists
say. "Certainly no one thinks that the increased
performance is due to mercury," says Davidson. The
scientists caution that the most obvious explanation --
that fish is so nutritious that those children who ate
more were healthier than those who didn't -- hasn't been
established because the study was not designed to look
at such a link. But these results do show that the tests
the team used are sensitive enough to detect very subtle
neurological and psychological effects in children, says
Davidson.
The Rochester findings are in contrast to those by a
team from the University of Odense in Denmark. That team
recently studied a population in the Faroe Islands, near
Iceland, that is exposed to mercury mainly by eating
whales as well as fish. Those scientists found that
children who were exposed to mercury pre- natally had
slight abnormalities in development at age seven.
The Rochester scientists feel those findings may be
relevant to people who eat whale meat but are not
convinced they apply to people eating fish and not
whale. Whale meat contains other toxins and pollutants,
like PCBs, and is higher in mercury than fish. Another
key difference is that a community often eats an entire
whale in a short period of time, causing a spike in
mercury levels that may affect the body differently than
lower levels.
The White House has organized a meeting for November
where the two teams and other scientists are expected to
discuss the varying results.
Besides Clarkson, Davidson, and Myers, the team also
included Christopher Cox, associate professor of
biostatistics; University of Rochester researchers
Catherine Axtell, Jean Sloane-Reeves, Elsa Cernichiari,
Anna Choi, and Yining Wang; Conrad Shamlaye of the
Republic of Seychelles Ministry of Health; Larry Needham
of the U.S. Centers for Disease Control and Prevention;
and Maths Berlin of the University of Lund in Sweden.
Editor's Note: The original news release can
be found at http://www.rochester.edu/pr/releases/med/mercury.htm

Age-Related
Cognitive Decline and Fish
Consumption - Omega-3 Fatty Acids Improve
Cognitive Function
Life Enhancement, June 2001, pp
12-15
In Gulliver's Travels, Jonathan Swift
described the Immortals from Luggnagg thus: ". . .
they never can amuse themselves with reading, because
their memory will not serve to carry them from the
beginning of a sentence to the end . . . ." While
the Luggnaggs may make your memory look sharp by
comparison, it's probably still safe to bet that you
forget where you put your car keys from time to time.
After all, we all have our memory lapses.
The sad fact is that, as we age, our
memory and our cognitive abilities in general are
destined to decline. But much research demonstrates that
certain fatty acids, especially the oils found in
cold-water fish, can be used to improve brain function,
reduce memory loss, and retard cognitive decline.
AGING BRINGS COGNITIVE DECLINE
Scientists are still not sure how or why we age.
But one thing is for sure - there's no way around
getting older. As we age, we are more likely to forget
birthdays, appointments, conversations, and other
important information. This so-called age-related
cognitive decline (ARCD) is marked by mild deterioration
in our memory, our performance of simple daily tasks,
and the speed of our mental processing.
Certain fatty acids, especially the
oils found in cold-water fish, can be used to improve
brain function, reduce memory loss, and retard
cognitive decline.
The causes of ARCD are largely unknown,
but recent research suggests that certain deleterious
conditions or activities, such as high blood pressure,
high levels of free radicals (reactive molecules that
cause oxidative damage), metabolic disorders, smoking,
low physical activity, and lack of mental challenge, may
accelerate the rate of memory loss and mental decline.
But we don't have to sit back and take
the aging process and its ensuing memory loss
complacently. On the contrary, we can and should be
proactive, taking advantage of current scientific
research that suggests that we can prevent or retard
ARCD. In this regard, it is instructive to consider the
role that fats and fatty acids may play in improving
cognitive function.
THE BRAIN NEEDS FATTY ACIDS
There appears to be a widespread public
misconception about dietary fat. The plain truth is that
the body and mind need dietary fat, in reasonable
quantities, to function optimally (or even at all -
without fat, we would die). Dietary fats are often
referred to as fatty acids, which simply means that a
long fat molecule has an acidic group attached to one
end. These fats come in a variety of types, including
saturated (meaning that there are no double bonds
between carbon atoms in the chain), monounsaturated (one
double bond), and polyunsaturated (two or more double
bonds). If this seems overly technical, just remember
that saturated fats, such as butter, tend to be solids
at room temperature, and unsaturated ones are usually
oils.
Monounsaturated fats (e.g., olive,
canola, and peanut oils) are generally considered to be
healthier than polyunsaturated fats (e.g., sunflower,
safflower, and corn oils). As we will see, however,
members of a certain class of polyunsaturated fats, the
omega-3 fatty acids, have many beneficial effects,
particularly with respect to cognition and memory; they
are also considered to be heart-healthy.
It has long been known that dietary fats
are beneficial to brain function. Brain tissue is
especially rich in these vital nutrients, which help to
ensure normal nerve-cell function, and the brain does
not function optimally if it is deprived of them. For
example, when laboratory rats are maintained on diets
deficient in polyunsaturated fatty acids such as
docosahexaenoic acid (it's an omega-3 fatty acid
found in fish oil), their learning and memory
capabilities are significantly impaired.1
A separate study shows that rats
initially maintained on a diet deficient in fish oil
have poor learning and memory skills. When they are
transferred to a diet supplemented with DHA, however,
they demonstrate dramatic improvement in learning and
memory.2
DHA is one of the primary fatty acids
found in fish oils. This molecule is very important in
the formation of the cellular membranes of nerve cells.
When DHA is in short supply, the structural and
functional integrity of the nerve cell is compromised.
Thus it is not surprising that a number of studies
demonstrate that DHA is required for normal brain
development in humans. In studies with infants, it has
been found that newborns supplemented with DHA exhibit
improved brain development, which allows them to process
information more rapidly.3
Much of the work with DHA thus far has
been performed on laboratory animals and has focused on
the memory of older animals. For example, when the diet
of older rats is supplemented with DHA, their memory
improves dramatically. After only four days of
supplementation, they need only half as much time to
find their way out of a maze as control rats that were
fed palm oil with no DHA.4 Based on
this and other information, many researchers believe
that an ample intake of omega-3 fatty acids such as DHA
may be especially beneficial in protecting against ARCD
in humans.
UNCHECKED ARCD MAY PROGRESS TO
DEMENTIA
We all realize that memory impairment is a
natural part of growing older, and minor memory lapses
are common. Cognitive decline as a result of aging can
mean many different things. The type of information that
is least easily recalled is generally nonessential and
may simply reflect "forgetfulness." However,
minor memory loss that progresses to a level where
recent events are not remembered and everyday tasks are
not performed properly may signal the onset of dementia.
DHA is one of the primary fatty
acids found in fish oils. This molecule is
very important in the formation of the cellular
membranes of nerve cells.
Dementia is a collective term that
denotes memory loss along with a decline in intellectual
functions, such as thinking and reasoning, in ways that
interfere with normal activities such as cooking,
household chores, and personal grooming. A persistent,
steady decline in these areas may signal the onset of
Alzheimer's disease, for example.
MEMORY DECLINE DUE TO AGING IS NOT
INEVITABLE
A recent paper in the Archives of Neurology by
Dr. Scott Small of Columbia University summarizes the
relationships between cognition, age, and memory loss
succinctly:5 "There is little
question that memory declines with age. Although there
is continued debate as to whether memory decline is
normal, epidemiological data suggest that components of
memory decline are not inevitable . . . ." Dr.
Small further suggests that, as research progresses and
the specific populations of neurons in regions of the
brain responsible for memory loss are identified, more
effective treatments for memory loss can be devised. One
natural approach that we already know about for
enhancing memory function is the omega-3 fatty acids
present in fish oils.
OMEGA-3 FATTY ACIDS IMPROVE
COGNITION
Current research efforts have identified a
number of potential memory boosters. Many of these are fish
oils rich in omega-3 fatty acids, such as DHA. In
fact, previous studies suggest that DHA levels in the
brain decrease with advancing age6 and
that humans with senile dementia treated for six months
with fish-oil capsules (1400 mg of DHA per day) show
improvement in intellectual function.7
A recent report demonstrates that the
levels of DHA are lower in the brains of Alzheimer's
patients than in those of normal elderly individuals.
The DHA levels are typically lower in the blood plasma
of AD patients also. These facts suggest that low DHA
levels may be a risk factor for developing Alzheimer's
disease.8
These facts suggest that low DHA
levels may be a risk factor for developing
Alzheimer's disease.
A separate study indicates that high
fish consumption is positively correlated with cognitive
function in older males.9
Researchers in Holland followed the dietary habits of
342 men from 1990 to 1993 and assessed their rate of
cognitive decline during that period. Of a number of
different dietary factors that were considered, only
high fish consumption seemed to prevent a decrease in
cognitive function over the study period.
OUR DIET IS DEFICIENT IN DHA
Not all fish are equally beneficial in this
respect. Cold-water fish, such as mackerel, herring,
salmon, and tuna, have the highest levels of omega-3
fatty acids and contribute the largest amount of DHA to
one's diet. A proposed recommended amount of DHA
(combined with another fish oil, eicosapentaenoic acid,
or EPA) is 0.65 g per day, which corresponds to two to
three servings of cold-water fish per week.10
One study suggests that attaining this intake of DHA in
the United States would require a quadrupling of our
fish consumption.11 Since it is
unlikely that this will happen anytime soon, if ever,
the majority of our population will probably continue to
receive an inadequate supply of omega-3 fatty acids.
Additional Benefits of Omega-3
Fatty Acids
Many different health benefits are attributed to the
versatile omega-3 fatty acids.13
Various studies have shown that they can help:
 |
Reduce the risk of heart disease and
stroke |
 |
Improve retinal and brain
development |
 |
Modulate some autoimmune diseases
(such as lupus and some kidney disorders) |
 |
Reduce the risk of breast, colon,
and prostate cancer |
 |
Reduce the symptoms of rheumatoid
arthritis |
 |
Alleviate mild hypertension (high
blood pressure) |
 |
Moderate Crohn's disease (a chronic
inflammation of the intestinal wall) |
Although our bodies are capable of
making DHA, this process is inefficient. The precursor
to DHA is alpha-linolenic acid (ALA), a molecule that
the body cannot synthesize, so it must be consumed in
the diet (walnuts and soybeans are two of the better
sources). But ALA is converted to DHA at a rate of only
3.8%.12 Given that Americans typically
consume only 1.11.6 g of ALA per day (the recommended
intake is 2.2 g), it is most unlikely that our bodies
are getting sufficient amounts of DHA from that
source.11 An inadequate supply of DHA may adversely
affect organs such as the brain, eyes, and nervous
system, which rely on this essential molecule.
References
- Geiner RS, Moriguchi T, Hutton A, Slotnick BM,
Salem N Jr. Rats with low levels of brain
docosahexaenoic acid show impaired performance in
olfactory-based and spatial learning tasks. Lipids
1999;34:S239-S243.
- Gamoh S, Hashimoto M, Sugioka K, et al. Chronic
administration of docosahexaenoic acid improves
reference memory-related learning ability in young
rats. Neuroscience 1999;93:237-41.
- Werkman SH, Carlson SE. A randomized trial of
visual attention of preterm infants fed
docosahexaenoic acid until nine months. Lipids
1996;31:91-7.
- Lim S-Y, Suzuki H. Intakes of dietary
docosahexaenoic acid ethyl ester and egg
phosphatidylcholine improve maze-learning ability in
young and old mice. J Nutr 2000;130:1629-32.
- Small SA. Age-related memory decline. Arch Neurol
2001;58:360-4.
- Suzuki H, Hayakawa S, Wada S. Effect of age on the
modification of brain polyunsaturated fatty acids
and enzyme activities by fish oil diet in rats. Mech
Aging Devel 1989;50:17-25.
- Miyanaga K, Ynoemura K, Takagi T, et al. Clinical
effects of DHA in demented patients. J Clin Ther Med
1995;11:881-901.
- Conquer JA, Tierney MC, Zecevic J, Bettger WJ,
Fisher RH. Fatty acid analysis of blood plasma of
patients with Alzheimer's disease, other types of
dementia, and cognitive impairment. Lipids
2000;35:1305-12.
- Kalmijn S, Feskens EJ, Launer LJ, Kromhout D.
Polyunsaturated fatty acids, antioxidants, and
cognitive function in very old men. Am J Epidemiol
1997;145:33-41.
- Simopolous AP, Leaf A, Salem N Jr. Essentiality of
and recommended dietary intakes for omega-6 and
omega-3 fatty acids. Ann Nutr Metab 1999;43:
127-130.
- Kris-Etherton PM, Taylor DS, Yu-Poth S, et al.
Polyunsaturated fatty acids in the food chain in the
United States. Am J Clin Nutr 2000;71:179S-188S.
- Gerster H. Can adults adequately convert alpha-linolenic
acid (18:3n-3) to eicosapentaenoic acid (20:5n-3)
and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr
Res 1998;68:159-73.
-
1.Connor WE. Importance of w-3 fatty
acids in health and disease. Am J Clin Nutr
2000;71:171S-175S.

Advantages
of a Mediterranean Diet
An additional approach to enhancing cognition may be
to adopt a "Mediterranean diet" rich in
unsaturated fatty acids. While such a diet has long been
advocated by cardiologists and nutritionists for reasons
of heart health, recent research indicates that it may
decrease the rate of memory loss as well. A study of 278
elderly individuals (6584 years of age) from
Casamassima in rural southern Italy revealed a strong
correlation between high monounsaturated fat intake and
improved cognitive performance.1 On average,
these individuals consumed 33% of their total calories
in the form of fat, and 17.6% of their total calories
came from monounsaturated fatty acids. Of the latter
amount, 85% was derived from olive oil, which means that
15% of their total calories came from olive oil.* These
individuals exhibited a very low incidence of ARCD.
- Solfrizzi V, Panza F, Torres F, et al. High
monounsaturated fatty acids intake protects against
age-related cognitive decline. Neurology
1999;52:1563-9.

Intake
of Fish and Omega-3 Fatty Acids and Risk of Stroke
in Women
Hiroyasu Iso, MD, PhD; Kathryn M.
Rexrode, MD, MPH; Meir J. Stampfer, MD, DrPH; JoAnn E.
Manson, MD, DrPH; Graham A. Colditz, MD, DrPH; Frank E.
Speizer, MD; Charles H. Hennekens, MD, DrPH; Walter C.
Willett, MD, DrPH
JAMA. 2001;285:304-312
http://jama.ama-assn.org/issues/v285n3/abs/joc92011.html
Context Some prospective studies
have shown an inverse association between fish intake
and risk of stroke, but none has examined the
relationship of fish and omega-3 polyunsaturated fatty
acid intake with risk of specific stroke subtypes.
Objective To examine the
association between fish and omega-3 polyunsaturated
fatty acid intake and risk of stroke subtypes in women.
Design, Setting, and Subjects Prospective
cohort study of women in the Nurses' Health Study
cohort, aged 34 to 59 years in 1980, who were free from
prior diagnosed cardiovascular disease, cancer, and
history of diabetes and hypercholesterolemia and who
completed a food frequency questionnaire including
consumption of fish and other frequently eaten foods.
The 79 839 women who met our eligibility criteria
were followed up for 14 years.
Main Outcome Measure Relative risk
of stroke in 1980-1994 compared by category of fish
intake and quintile of omega-3 polyunsaturated fatty
acid intake.
Results After 1 086 261
person-years of follow-up, 574 incident strokes were
documented, including 119 subarachnoid hemorrhages, 62
intraparenchymal hemorrhages, 303 ischemic strokes (264
thrombotic and 39 embolic infarctions), and 90 strokes
of undetermined type. Among thrombotic infarctions, 90
large-artery occlusive infarctions and 142 lacunar
infarctions were identified. Compared with women who ate
fish less than once per month, those with higher intake
of fish had a lower risk of total stroke: the
multivariate relative risks (RRs), adjusted for age,
smoking, and other cardiovascular risk factors, were
0.93 (95% confidence interval [CI], 0.65-1.34) for fish
consumption 1 to 3 times per month, 0.78 (95% CI,
0.55-1.12) for once per week, 0.73 (95% CI, 0.47-1.14)
for 2 to 4 times per week, and 0.48 (95% CI, 0.21-1.06)
for 5 or more times per week (P for trend = .06).
Among stroke subtypes, a significantly reduced risk of
thrombotic infarction was found among women who ate fish
2 or more times per week (multivariate RR, 0.49; 95% CI,
0.26-0.93). Women in the highest quintile of intake of
long-chain omega-3 polyunsaturated fatty acids had
reduced risk of total stroke and thrombotic infarction,
with multivariate RRs of 0.72 (95% CI, 0.53-0.99) and
0.67 (95% CI, 0.42-1.07), respectively. When stratified
by aspirin use, fish and omega-3 polyunsaturated fatty
acid intakes were inversely associated with risk of
thrombotic infarction, primarily among women who did not
regularly take aspirin. There was no association between
fish or omega-3 polyunsaturated fatty acid intake and
risk of hemorrhagic stroke.
Conclusions Our data indicate that
higher consumption of fish and omega-3 polyunsaturated
fatty acids is associated with a reduced risk of
thrombotic infarction, primarily among women who do not
take aspirin regularly, but is not related to risk of
hemorrhagic stroke.

Eating
Fatty Fish May Reduce Risk Of Prostate Cancer
http://unisci.com/stories/20012/0601013.htm
Consumption of fatty fish such as
salmon, herring and mackerel could reduce the risk of
prostate cancer, report the authors of a research letter
in this week's issue of The Lancet.
Essential fatty acids -- especially omega-3 fatty
acids contained in large amounts in fatty fish -- have
previously proved to inhibit the growth of prostate
cancer cells.
Paul Terry and colleagues from the Karolinska
Institute, Stockholm, Sweden, prospectively assessed
over 6,000 Swedish men to establish whether eating fatty
fish would reduce the risk of prostate cancer.
Participants' lifestyles were assessed by
questionnaire, which included questions relating to
diet, smoking habits, alcohol consumption and physical
activity.
The men were followed up between 1967 and 1997, and
prostate cancer incidence and mortality was calculated
by linkage to the Swedish National Cancer Register and
National Death Register.
During the 30-year follow-up period there were 466
diagnoses of prostate cancer, of which 340 were fatal.
The men who ate no fish had a two-fold to three-fold
higher risk of prostate cancer than those who ate
moderate or high amounts.
Paul Terry comments, "Our study was done in
Sweden, a country with traditionally high consumption of
fatty fish from Northern (cold) waters, which contain
high amounts of omega-3 fatty acids.
"Since few dietary and other modifiable factors
seem to be associated with lower risk of prostate
cancer, our results may indicate an important means by
which this disease might be prevented."
(Reference: The Lancet, 2nd June 2001)
[Contact: Professor
Alicja Wolk]
01-Jun-2001

Fatty
fish consumption and risk of prostate
cancer
Paul Terry, Paul
Lichtenstein, Maria Feychting, Anders Ahlbom, Alicja
Wolk
The Lancet, Volume 357, Number 9270,
02 June 2001
http://www.thelancet.com/journal/journal.isa
Consumption of fatty fish might
reduce the risk of prostate cancer, although
epidemiological studies of fish consumption are rare. We
studied the association between fish consumption and
prostate cancer in a population-based prospective cohort
of 6272 Swedish men. During 30 years of follow-up, men
who ate no fish had a two-fold to three-fold higher
frequency of prostate cancer than those who ate moderate
or high amounts did. Our results suggest that fish
consumption could be associated with decreased risk of
prostate cancer.
Essential fatty acids contained in fish inhibit the
growth of prostate cancer cells in vitro and in vivo.1
Moreover, results of ecological cross-national studies
and a case-control study,2 which investigated
the concentration of fatty acids in the serum, support
an inverse association between fatty acids from fish and
prostate cancer. However, epidemiological studies of
fish consumption and prostate cancer risk in human
populations are scarce and have included only small
numbers of participants. Furthermore, such studies often
measure only a small variation in fish consumption and
lack controls for confounding variables. Finally, the
type of fish studied is often not described.3
Only fish high in omega-3 fatty acids are likely to
lower the risk of prostate cancer.1 We
examined fish consumption in relation to prostate cancer
in a population-based prospective cohort study in
Sweden, a country with a traditionally high consumption
of fatty fish from Northern (cold) waters, such as
salmon, herring, and mackerel, which contain high
amounts of omega-3 fatty acids.
We sent questionnaires to twin pairs born between
1886 and 1925. All twins were living in Sweden in 1961
and were included in the Swedish twin registry. Of 12
889 registered twin pairs of both sexes, 10 942
responded to our initial questionnaire in 1961. In 1967,
a 107-item questionnaire, investigating life-style
factors, was mailed to those registered. We excluded 556
patients who died before assessment and 136 with cancer
at baseline. Our analysis was based on the remaining
6272 men who responded. We assessed consumption of fish
and other foods by single questions on a four-point
relative scale. We asked participants whether various
foodtypes accounted for none or a very little part of
their diet, a small part, a moderate part, or a large
part. We assessed smoking habit and recorded men as
being never, former, or current (1-10, 11-20, and >21
cigarettes daily) smokers. We assessed alcohol
consumption as number of drinks (13·2 g alcohol/drink)
consumed every week, and physical activity on a relative
scale: hardly any physical exercise, light exercise
(regular walks, light gardening), regular exercise, and
hard physical training.
We followed men from exposure assessment to diagnosis
of prostate cancer, death, or end of follow-up on Dec
31, 1997, through linkage to the National Cancer
Register and Death Causes Register. We used Cox
proportional hazard models, which adjusted variance
estimates for correlated outcomes, to estimate hazard
rate ratios with 95% CI. We investigated the
proportional hazards assumption by including
time-varying covariates in the model and by plotting the
log cumulative hazards function. Since the greatest
number of prostate cancer diagnoses were recorded for
moderate fish consumption, we used this category as the
referent in our analyses.
The mean age at baseline was 55·6 (SD 9·1) years.
During follow-up of up to 30 years (133 839
person-years), with an average of 21·4 years, there
were 466 diagnoses of prostate cancer (340 were fatal),
diagnosed at a mean age of 76·7 (8·3) years. High
consumption of fish was positively associated with
physical activity, smoking, and consumption of fruit and
vegetables, and inversely associated with consumption of
red meat and processed meat (table 1).

|
Fish
consumption |
|
Never/seldom
(n=124) |
Small part
(n=2621) |
Moderate
part (n=2978) |
Large part
(n=549) |
| Characteristic |
| Person
years |
2406 |
55753 |
64458 |
11222 |
| Prostate
cancer |
14 |
201 |
209 |
42 |
| Age at
baseline (median [range]) (years) |
57
(43-82) |
54
(43-82) |
53
(43-82) |
55
(43-82) |
| Body
mass index (median [range]) (kg/m2) |
24·3 (19·7-32·4) |
24·6 (18·9-32·3) |
24·4 (19·9-32·4) |
24·7 (19·5-33·3) |
| Sedentary
lifestyle |
29 (23%) |
315 (12%) |
298 (10%) |
49 (9%) |
| Low
socioeconomic status |
69 (56%) |
1311
(50%) |
1489
(50%) |
324 (59%) |
| Never
smoked |
64 (56%) |
1101
(42%) |
1161
(39%) |
165 (30%) |
| Alcohol
(median [range]) (drinks/week) |
1 (0-18) |
3 (0-15) |
3 (0-17) |
3 (0-18) |
| High
consumption foods |
| Red meat |
16 (13%) |
52 (2%) |
30 (1%) |
11 (2%) |
| Processed
meat |
9 (7%) |
5 (0·2%) |
15 (0·5%) |
5 (1%) |
| Milk |
4 (3%) |
105 (4%) |
89 (3%) |
11 (2%) |
| Fruit
and vegetables |
12 (10%) |
157 (6%) |
357 (12%) |
181 (33%) |
| Table
1: Baseline characteristics |

An increasing proportion of
fish in the diet was associated with a decreasing
frequency of prostate cancer in both age-adjusted and
multivariate-adjusted risk-factor models (table 2).
Adjustment for other dietary and lifestyle factors
listed in the table strengthened the association, which
was also strongest for men who died as a result of their
prostate cancer. Controlling for genetic and shared
environmental factors by restricting the analyses to
only discordant monozygotic pairs did not alter our
results.

|
Fish
consumption |
|
Never/seldom |
Small part |
Moderate
part |
Large part |
p§ |
| All
prostate cancers |
| Number
of diagnoses |
14 |
201 |
209 |
42 |
| Age
adjusted RR (95% CI) |
1·7 (1·0-3·0) |
1·1 (0·9-1·3) |
Referent |
1·1 (0·8-1·5) |
0·35 |
| Multivariate
RR (95% CI)* |
2·3 (1·2-4·5)† |
1·2 (1·0-1·4) |
Referent |
1·0 (0·7-1·6) |
0·05 |
| Prostate
cancer death |
| Number
of diagnoses |
12 |
145 |
152 |
31 |
| Age
adjusted RR (95% CI) |
2·1 (1·1-3·7)† |
1·1 (0·9-1·4) |
Referent |
1·1 (0·8-1·7) |
0·39 |
| Multivariate
RR (95% CI)* |
3·3 (1·8-6·0)‡ |
1·3 (1·0-1·6) |
Referent |
0·9 (0·6-1·7) |
0·01 |
| RR=risk
ratio.*Multivariate models adjusted for age (in
5-year age groups), body mass index (in
quartiles), physical activity, smoking, and
consumption of alcohol, red meat, processed meat,
fruit and vegetables, and milk (in quartiles);
†p<0·05; ‡p<0·01. §for test of trend. |
Table 2: Rate ratios of prostate cancer according
to fish consumption
The strengths of our study
include the population-based character of our cohort,
assessment of information on potentially confounding
variables, and assessment of exposure before disease
occurrence, which reduces the potential for information
bias from selective recall. Additionally, the wide range
of fatty fish consumed in Sweden, the long follow-up,
and the nearly complete end-point ascertainment, which
reduces the potential for bias from differential
follow-up, add weight to our results. Adjustment for
confounding variables, including genetic and shared
environmental factors, strengthened rather than weakened
our results. Moreover, the stronger association that we
recorded for prostate cancer deaths than for other
deaths suggests that our results are not a product of
detection bias.
Our data were limited by the likelihood of some
degree of measurement error, with respect to the long
follow-up without further assessment of diet.
Nonetheless, non-differential misclassification of
exposure would tend to attenuate, rather than
exaggerate, our rate ratio estimates. Although we
adjusted our rate ratio estimates for factors possibly
associated with prostate cancer, other unidentified
factors might partly account for the recorded inverse
association with fish consumption.
Our results support the hypothesis that fatty fish
consumption lowers the risk of prostate cancer, possibly
through inhibition of arachidonic acid-derived
eicosanoid biosynthesis. Results of a cross-sectional
study within the European Prospective Investigation into
Cancer and Nutrition (EPIC) cohort in 16 regions of
Europe showed greatly increased (three-fold to
four-fold) plasma concentrations of eicosapentaenoic
acid (EPA) in people from Sweden and Denmark who
consumed high amounts of fatty fish.4 EPA
competes with arachidonic acid as a substrate for
cyclo-oxygenases and, therefore, high concentrations of
EPA can lead to important changes in relative
concentrations of tumour growth enhancing
prostaglandins.5
The Swedish Twin Registry is supported by grants from
the Swedish Cancer Society, the John D and Catherine T
MacArthur Foundation, and the Swedish Council for
Planning and Coordination of Research (FRN).
- Rose DP. Effects of dietary fatty acids on breast
and prostate cancers: evidence from in vitro
experiments and animal studies. Am J Clin
Nutr 1997; 66 :(suppl) 1513S-22S. [PubMed]
- Norrish AE, Skeaff CM, Arribas GL, Sharpe SJ,
Jackson RT. Prostate cancer risk and consumption of
fish oils: a dietary biomarker-based case-control
study. Br J Cancer 1999; 81: 1238-42. [PubMed]
- Kolonel LN. Nutrition and prostate cancer. Cancer
Causes Control 1996; 7: 83-94. [PubMed]
- Anon. Interim annual report. Lyon: International
Agency for Research on Cancer, 2000; 15.
- Galli C, Butrum R. Dietary omega 3 fatty acids and
cancer: an overview. World Rev Nutr Diet 1991; 66: 446-61. [PubMed]
Department of Medical
Epidemiology (P Terry PhD,
P Lichtenstein PhD, A Wolk Dr Med Sc) and Department
of Environmental Medicine (M Feychting PhD, Prof A
Ahlbom PhD), Karolinska Institutet, Stockholm, Sweden
Correspondence to: Dr
Paul Terry (e-mail:paul.terry@mep.ki.se)

Fish
Consumption and Risk of Sudden Cardiac
Death
Christine M. Albert, MD; Charles H.
Hennekens, MD; Christopher J. O'Donnell, MD; Umed A.
Ajani, MBBS; Vincent J. Carey, PhD; Walter C. Willett,
MD; Jeremy N. Ruskin, MD; JoAnn E. Manson, MD
JAMA. 1998;279:23-28
http://jama.ama-assn.org/issues/v279n1/abs/joc71267.html
Context. Dietary fish intake has
been associated with a reduced risk of fatal cardiac end
points, but not with nonfatal end points. Dietary fish
intake may have a selective benefit on fatal arrhythmias
and therefore sudden cardiac death.
Objective. To investigate
prospectively the association between fish consumption
and the risk of sudden cardiac death.
Design. Prospective cohort study.
Setting. The US Physicians' Health
Study.
Patients. A total of 20551 US male
physicians 40 to 84 years of age and free of myocardial
infarction, cerebrovascular disease, and cancer at
baseline who completed an abbreviated, semiquantitative
food frequency questionnaire on fish consumption and
were then followed up to 11 years.
Main Outcome Measure. Incidence of
sudden cardiac death (death within 1 hour of symptom
onset) as ascertained by hospital records and reports of
next of kin.
Results. There were 133 sudden
deaths over the course of the study. After controlling
for age, randomized aspirin and beta carotene
assignment, and coronary risk factors, dietary fish
intake was associated with a reduced risk of sudden
death, with an apparent threshold effect at a
consumption level of 1 fish meal per week (P for
trend=.03). For men who consumed fish at least once per
week, the multivariate relative risk of sudden death was
0.48 (95% confidence interval, 0.24-0.96; P =.04)
compared with men who consumed fish less than monthly.
Estimated dietary n-3 fatty acid intake from seafood
also was associated with a reduced risk of sudden death
but without a significant trend across increasing
categories of intake. Neither dietary fish consumption
nor n-3 fatty acid intake was associated with a reduced
risk of total myocardial infarction, nonsudden cardiac
death, or total cardiovascular mortality. However, fish
consumption was associated with a significantly reduced
risk of total mortality.
Conclusion. These prospective data
suggest that consumption of fish at least once per week
may reduce the risk of sudden cardiac death in men.

More News on the
Benefits of Fish Consumption from
The Durk
Pearson & Sandy Shaw Life Extension News
Volume 4 No. 4, July 2001
http://www.life-enhancement.com/displayart.asp?ID=601
HEART-RATE
VARIABILITY CORRELATED WITH n-3 FATTY ACIDS
Reduced heart-rate variability (HRV) is a predictor of
arrhythmia and sudden cardiac death and is also known to
be associated with age. A recent Danish study has found
dietary intake of n-3 fatty acids and wine to
be correlated with HRV. (However, after controlling for n-3
fatty acids, the correlation between wine and HRV was no
longer significant. Apparently, at least in these Danish
subjects, those who consumed high levels of fish were
likely also to drink higher levels of wine.) Additional
research1
on the patients in that study verified the patients'
dietary intake of n-3 fatty acids (through consumption
of fish) by measuring the n-3 fatty acid
composition of the patients' blood granulocyte membranes
and adipose (fat) tissue. The researchers found the
level of docosahexaenoic acid (DHA) in granulocytes had
the highest correlation with HRV.
The accompanying editorial by J. Thomas Bigger, Jr.,
and Terek El-Sherif stated that "The details of the
antiarrhythmic action for n-3 PUFA [polyunsaturated
fatty acids] remain to be elucidated . . .
but the overall body of evidence from epidemiological
studies and two clinical trials suggests that n-3
PUFA have an important antiarrhythmic effect in patients
with coronary heart disease. Unfortunately, coronary
heart disease is often announced by sudden cardiac
death. Given the safety and low cost of implementing
a recommendation for a modest amount of fish in the
diet, adequate dietary fish intake has a significant
role to play in the primary and secondary prevention of
out-of-hospital sudden cardiac death."
The American Heart Association, publisher of Circulation,
now recommends increased fish consumption to at
least two fish servings per week. Their latest
recommendation notes that "Because of the
beneficial effects of n-3 fatty acids on risk
of coronary artery disease as well as other diseases
such as inflammatory and autoimmune diseases, the
current intake, which is generally low, should be
increased."
- Inform,
June 2001, p. 619*
*Inform is
published by the American Oil Chemists Society as a
source of international news on research and development
of fats, oils, and related materials.
Reference
1. Circulation 103:651-657 (2001), as
reported in Inform, June 2001, p. 618.

LIFE EXTENSION WITH
FATTY FISH
Dariush Mozaffarian of the University of Washington
Veterans Affairs Medical Center in Seattle, Washington,
reported at the 41st Annual Conference on Cardiovascular
Disease Epidemiology and Prevention in San Antonio,
Texas, that, in a study group of average age 72 years,
eating fatty fish (such as tuna, salmon, and mackerel,
but not fried lean fish, such as cod and snapper) at
least once a week was found to lead to a 44% lower
risk of dying from a heart attack.
- Inform,
May 2001, p. 500

FATTY
FISH CONSUMPTION AND RISK OF PROSTATE CANCER
A new paper published in The Lancet1 reports an epidemiological study of 6272
Swedish men followed for 30 years. They found that the
men who ate no fish had a two-fold to three-fold higher
frequency of prostate cancer than did those who ate
moderate or high amounts. The authors propose that
". . . fish consumption could be
associated with decreased risk of prostate cancer."
One of the n-3 fatty acids, eicosapentaenoic
acid (EPA), competes with arachidonic acid as a
substrate for cyclooxygenases and can therefore have an
important effect on the formation of
tumor-growth-enhancing prostaglandins.
Reference
1. Terry et al., "Fatty Fish
Consumption and Risk of Prostate Cancer," The
Lancet 357:1764-1766 (2001). |